Back to Authors

Harpaz, N

A5138131942 | I98704320

Mayo Clinic

Icahn School of Medicine at Mount Sinai

Citations 1

Mirikizumab Demonstrates Long-Term Efficacy on Histological Resolution in the Phase 3, Multicenter, Open-Label VIVID-2 Extension Study

Zeitschrift für Gastroenterologie | June 8, 2026 | Volume: 64 | Issue: 05 | Pages: e139-e140

10.1055/s-0046-1823082